News

You are here

VAX-ID intradermal drug delivery device
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...
Novosanis will present its VAX-ID™ device platform during BioJapan
"High Frequency Ultrasound to Assess Skin Thickness in Healthy Adults” published in the prestigious peer-reviewed journal VACCINE.
Novosanis announced today their collaboration with ImevaX, a biopharmaceutical company based in Munich, Germany

Pages